Suppr超能文献

基于数据挖掘的THY1在胃癌中的多重作用

Multiple roles of THY1 in gastric cancer based on data mining.

作者信息

Hu Yun, Jin Dongmei, Zhou Yichan, Cheng Ye, Cao Hongyong, Ma Yong, Zhang Wenling

机构信息

Department of General Surgery, Nanjing First Hospital, Nanjing Medical University, Nanjing 210006, China.

Department of General Surgery, Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research & The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing 2310442, China.

出版信息

Transl Cancer Res. 2020 Apr;9(4):2748-2757. doi: 10.21037/tcr.2020.02.51.

Abstract

BACKGROUND

THY1 (CD90) is a heavily N-glycosylated, glycophosphatidylinositol (GPI) anchored cell surface protein, which has been implicated in several cancers. But, the specific mechanism and function of the THY1 gene remains unclear in gastric cancer (GC).

METHODS

To investigate the function of THY1 in GC and illustrate the potential mechanism, TCGA and FIREBROWSE were used to detect the THY1expression. GEPIA2 and Kaplan-Meier Plotter showed significant correlation among THY1 mRNA level, TNM stage and survival probability of GC patients.

RESULTS

THY1 was up-regulated apparently in GC in contrast to normal tissues and linked to TNM stage. GC patients with higher THY1 expression displayed lower overall survival (OS), first progression (FP) and post-progression survival (PPS). In vitro experiments showed that knockdown of THY1 suppressed proliferation, migration while increased autophagy level in GC cells. Immune factors may interact with THY1mRNA in GC and THY1 was found significantly linked with Tregs.

CONCLUSIONS

Our findings indicate that higher THY1 level is link to poor prognosis of GC patients. THY1may as well be used as a marker molecule for evaluating the tumor microenvironment status of GC patients and a target for immunotherapy.

摘要

背景

THY1(CD90)是一种高度N-糖基化、糖磷脂酰肌醇(GPI)锚定的细胞表面蛋白,与多种癌症有关。但是,THY1基因在胃癌(GC)中的具体机制和功能仍不清楚。

方法

为了研究THY1在GC中的功能并阐明潜在机制,使用TCGA和FIREBROWSE检测THY1表达。GEPIA2和Kaplan-Meier Plotter显示THY1 mRNA水平、TNM分期与GC患者生存概率之间存在显著相关性。

结果

与正常组织相比,THY1在GC中明显上调,并与TNM分期相关。THY1表达较高的GC患者总体生存期(OS)、首次进展期(FP)和进展后生存期(PPS)较低。体外实验表明,敲低THY1可抑制GC细胞增殖、迁移,同时提高自噬水平。免疫因子可能在GC中与THY1 mRNA相互作用,并且发现THY1与调节性T细胞(Tregs)显著相关。

结论

我们的研究结果表明,较高的THY1水平与GC患者的不良预后相关。THY1也可作为评估GC患者肿瘤微环境状态的标志物分子和免疫治疗靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b246/8798632/285da0ab21d5/tcr-09-04-2748-f1.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验